IDiyas

For the Inventor, By the Inventor

Netanya, Israel

Anton Frenkel

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 255(Granted Patents)


Location History:

  • Modiin, IL (2001 - 2009)
  • Netanya, IL (2009 - 2024)

Company Filing History:

goldMedal18 out of 505 
 
Teva Pharmaceutical Industries Limited
 patents
silverMedal1 out of 1,168 
 
Yeda Research and Develpment & Co. Ltd
 patents
bronzeMedal2 out of 832,680 
Other
 patents

Years Active: 2001-2024

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents
1. 11897858 - Salt and solid state forms of escatalopram (2024-02-13),
2. 11390597 - Salt and solid state forms of escitalopram (2022-07-19),
3. 9346746 - R(+)-N-formyl-propargyl-aminoindan (2016-05-24),
4. 9339469 - R(+)-N-methyl-propargyl-aminoindan (2016-05-17),
5. 9233927 - Crystals of laquinimod sodium and improved process for the manufacture thereof (2016-01-12),
6. 8975279 - Amine salts of laquinimod (2015-03-10),
7. 8673322 - Crystals of laquinimod sodium, and process for the manufacture thereof (2014-03-18),
8. 8647646 - Crystals of laquinimod sodium, and process for the manufacture thereof (2014-02-11),
9. 8614252 - Crystalline solid rasagiline base (2013-12-24),
10. 8334409 - Process for purifying rasagiline base (2012-12-18),
11. 8163960 - Process for preparing and drying solid rasagiline base (2012-04-24),
12. 8080584 - Delayed release rasagiline citrate formulation (2011-12-20),
13. 7968749 - Process for preparing and drying solid rasagiline base (2011-06-28),
14. 7884208 - Crystals of laquinimod sodium, and process for the manufacture thereof (2011-02-08),
15. 7855233 - Citrate salt of Rasagiline (2010-12-21),

Title: Innovator Spotlight - Anton Frenkel: Pioneering Pharmaceuticals

Introduction: Anton Frenkel, a distinguished inventor based in Netanya, Israel, has made significant contributions to the field of pharmaceuticals with a total of 21 patents to his name.

Latest Patents: Among his impressive portfolio, his latest breakthrough includes the development of a new salt and solid state forms of escitalopram. This innovation encompasses processes for preparation, pharmaceutical compositions, and methods of use, representing a significant advancement in the medical industry.

Career Highlights: Anton Frenkel has notably lent his expertise to renowned companies such as Teva Pharmaceutical Industries Limited, a global leader in generic medicines. His role in these institutions has undoubtedly played a pivotal part in shaping the pharmaceutical landscape.

Collaborations: Throughout his career, Frenkel has collaborated with industry peers such as Avital Laxer and Ramy Lidor-Hadas, highlighting his ability to work effectively within multidisciplinary teams to drive innovation forward.

Conclusion: Anton Frenkel's remarkable journey as an inventor showcases his unwavering dedication to pushing the boundaries of pharmaceutical research. His pioneering work continues to leave a lasting impact on the field, setting a high standard for future innovators to aspire to.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…